Related Experiment Videos

Disparities in subgroup populations enrolled in lung cancer trials

Antonio Rossi1, Giovanni Palazzolo, Domenico Galetta

  • 1Division of Medical Oncology, SG Moscati Hospital, Contrada Amoretta, 8 83100, Avellino, Italy. arossi_it@yahoo.it

Expert Review of Respiratory Medicine
|March 30, 2012
PubMed

Insights

Clinical trials for lung cancer drugs may not represent all patient groups. This study examines how factors like age, gender, and ethnicity impact trial results and drug efficacy for diverse populations.

Area of Science:

  • Oncology
  • Clinical Trials
  • Health Disparities

Background:

  • Lung cancer is a leading cause of global cancer mortality.
  • Approved lung cancer treatments stem from pivotal clinical studies.
  • Patient accrual in clinical trials often shows disparities in age, gender, and ethnicity.

Purpose of the Study:

  • To analyze the impact of patient characteristics on clinical trial outcomes.
  • To investigate potential generalizability issues of drug efficacy across diverse populations.
  • To highlight the importance of representative patient subgroups in lung cancer research.

Main Methods:

  • Review of existing literature on randomized clinical trials in lung cancer.
  • Examination of data concerning patient demographics (age, gender, ethnicity) in trial enrollment.
  • Discussion of the implications of subgroup representation on reported treatment efficacy.

Main Results:

  • Clinical trials frequently underrepresent specific demographic groups.
  • Generalizing trial findings across all patient populations may obscure subgroup-specific treatment effects.
  • Variations in age, gender, and ethnicity can influence treatment response and outcomes.

Conclusions:

  • Ensuring diverse patient representation in clinical trials is crucial for accurate lung cancer treatment evaluation.
  • Further research is needed to understand subgroup-specific responses to lung cancer therapies.
  • Clinical guidelines should consider the impact of patient characteristics on treatment effectiveness.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...